TXNIP and neoplasm: Consistent with a tumor suppressor role, we have previously shown that endogenous TXNIP expression is reduced in the M12 metastatic prostate cancer cell line relative to its benign counterpart, and that ectopic TXNIP overexpression in metastatic prostate cancer leads to cell death [48].